Ajanta Pharma Ltd.
Ajanta Pharma Ltd.
- Mkt Cap (₹ Cr.)
- P/E (x)
- P/B (x)
- Div_ Yield (%)
- BETABETA1 Month3-Months6-Months1 Year3-Years
- Face Value (₹)2.00
- EPS-TTM (Rs.)53.60
- BV/share (₹)296.34
- 52Wk L/H825.00/ 1572.50
- Avg. Daily Volatility %Avg. Daily Volatility %1 Month3-Months6-Months1 Year3-Years
Ajanta Pharma Ltd. Share Price Updates
Ajanta Pharma Ltd. Quarterly Results
Ajanta Pharma Ltd Share Price
Ajanta Pharma Ltd Risk Return Comparisonwith peersNew
Ajanta Pharma Ltd Financial Comparisonwith peers
Ajanta Pharma Ltd Share Holding as on 31-03-2020
|Category||No. of shares||Percentage|
MF Ownership Of Ajanta Pharma Ltd. Shares
Mirae Asset Large Cap Fund Direct- GrowthPortfolio as on 30-04-2020
Liquid, Ultra Short Term funds and FMPs are not taken into account.More Schemes
About Ajanta Pharma Ltd.
Ajanta Pharma Ltd., incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 13254.55 Crore) operating in Pharmaceuticals sector.
Ajanta Pharma Ltd. key Products/Revenue Segments include Pharmaceutical Products which contributed Rs 1762.69 Crore to Sales Value (96.29 % of Total Sales), Export Incentives which contributed Rs 66.17 Crore to Sales Value (3.61 % of Total Sales) and Other Operating Revenue which contributed Rs 1.59 Crore to Sales Value (0.08 % of Total Sales)for the year ending 31-Mar-2018.
For the quarter ended 31-03-2020, the company has reported a Consolidated sales of Rs 681.96 Crore, up 4.72 % from last quarter Sales of Rs 651.21 Crore and up 32.38 % from last year same quarter Sales of Rs 515.16 Crore Company has reported net profit after tax of Rs 129.16 Crore in latest quarter.
The company’s top management includes Dr.Anjana Grewal, Mr.Chandrakant M Khetan, Mr.K H Viswanathan, Mr.Madhusudan B Agrawal, Mr.Mannalal B Agrawal, Mr.Prabhakar R Dalal, Mr.Rajesh M Agrawal, Mr.Yogesh M Agrawal. Company has B S R & Co. LLP as its auditors As on 31-03-2020, the company has a total of 87,261,270 shares outstanding.